Home › Compare › DVCR vs JNJ

DVCR vs JNJ: Dividend Comparison 2026

DVCR yields 20.52% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.9K in total portfolio value· pulled ahead in Year 8
10 years
DVCR
DVCR
● Live price
20.52%
Share price
$10.09
Annual div
$2.07
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$2.38
Full DVCR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — DVCR vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDVCRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DVCR + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DVCR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVCR
Annual income on $10K today (after 15% tax)
$1,743.81/yr
After 10yr DRIP, annual income (after tax)
$2.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,983.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVCR + JNJ for your $10,000?

DVCR: 50%JNJ: 50%
100% JNJ50/50100% DVCR
Portfolio after 10yr
$26.8K
Annual income
$2,345.89/yr
Blended yield
8.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DVCR
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVCR buys
0
JNJ buys
0
No recent congressional trades found for DVCR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDVCRJNJ
Forward yield20.52% ✓2.13%
Annual dividend / share$2.07$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28% ✓
Portfolio after 10y$23.4K$30.3K ✓
Annual income after 10y$2.38$4,689.40 ✓
Total dividends collected$2.2K$15.4K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DVCR vs JNJ ($10,000, DRIP)

YearDVCR PortfolioDVCR Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,726$1,025.77$10,592$272.30+$1.1K → DVCR
2$13,109$562.05$11,289$357.73+$1.8K → DVCR
3$14,320$293.62$12,123$472.89+$2.2K → DVCR
4$15,472$149.88$13,141$629.86+$2.3K → DVCR
5$16,631$75.67$14,408$846.81+$2.2K → DVCR
6$17,833$38.01$16,021$1,151.60+$1.8K → DVCR
7$19,100$19.05$18,122$1,588.22+$978.00 → DVCR
8← crossover$20,447$9.53$20,930$2,228.20$483.00 → JNJ
9$21,883$4.77$24,792$3,191.91$2.9K → JNJ
10$23,417$2.38$30,274$4,689.40$6.9K → JNJ

DVCR vs JNJ: Complete Analysis 2026

DVCR — Stock

Diversicare Healthcare Services, Inc. provides post-acute care services. The company is headquartered in Brentwood, Tennessee and currently employs 4,500 full-time employees. The firm's post-acute care services to patients and residents include skilled nursing, ancillary healthcare services and assisted living. In addition to the nursing, personal care and social services that are provided in long-term care centers, the Company offers a range of rehabilitative, respiratory and other ancillary services. The firm operates 77 skilled nursing and long-term care facilities containing 8,556 skilled nursing beds. The firm's nursing centers range in size from 48 to 320 licensed nursing beds. The nursing centers provide nursing healthcare services, including nutrition services, recreational therapy, social services and laundry services. The firm operates in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee and Texas.

Full DVCR Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this DVCR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVCR vs SCHDDVCR vs JEPIDVCR vs ODVCR vs KODVCR vs MAINDVCR vs ABBVDVCR vs MRKDVCR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.